Effective chemotherapy for melanoma after treatment with interleukin-2
Open Access
- 15 January 1992
- Vol. 69 (2) , 427-429
- https://doi.org/10.1002/1097-0142(19920115)69:2<427::aid-cncr2820690225>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Potentiation of Human Natural Killer Cell Activity by Recombinant Interleukin-2 towards Multidrug-Resistant Human Epidermoid CarcinomaPathobiology, 1990
- Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agentsCellular Immunology, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985